Prior thiazide diuretic treatment increases adrenaline-induced hypokalaemia.
Hypokalaemia is a common finding in acutely ill patients and may be related in part to increased sympathoadrenal activity. In an investigation to determine whether pretreatment with thiazide diuretics causes the serum potassium to fall to an even lower level during increased sympathoadrenal activity, adrenaline was infused into healthy subjects after pretreatment for 7 days with either bendrofluazide (5 mg) or placebo. Thiazide diuretic pretreatment had no effect on the adrenaline-induced changes in blood pressure and heart rate. However, not only was the baseline serum potassium lower after bendrofluazide (3 . 40 mmol/l vs 3 . 83 mmol/l) but the serum potassium also fell to a significantly lower level during adrenaline infusion after bendrofluazide (2 . 73 mmol/l vs 3 . 08 mmol/l). Transient profound hypokalaemia may increase the risk of ventricular arrhythmias in patients on diuretics, and routine monitoring of the resting serum potassium may underestimate this risk.
D000328:Adult; D001539:Bendroflumethiazide / Q000009:adverse effects; D001794:Blood Pressure / Q000187:drug effects; D002986:Clinical Trials as Topic; D004232:Diuretics; D004562:Electrocardiography; D004837:Epinephrine / Q000097:blood* / Q000494:pharmacology; D005947:Glucose / Q000008:administration & dosage; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D007008:Hypokalemia / Q000139:chemically induced* / Q000503:physiopathology; D007263:Infusions, Parenteral; D011188:Potassium / Q000097:blood*; D049993:Sodium Chloride Symporter Inhibitors / Q000009:adverse effects*; D013997:Time Factors
D004232:Diuretics; D049993:Sodium Chloride Symporter Inhibitors; D001539:Bendroflumethiazide; D005947:Glucose; D011188:Potassium; D004837:Epinephrine